National Oesophago-Gastric Cancer Audit, 2014

Making clinical audit data transparent.

In his transparency and open data letter to Cabinet Ministers on 7 July 2011, the Prime Minister made a commitment to make clinical audit data available from the national audits within the National Clinical Audit and Patient Outcomes Programme.

The National Oesophago-Gastric Cancer Audit covers the quality of care given to patients with Oesophago-Gastric (OG) cancer. The audit evaluates the process of care and the outcomes of treatment for all OG cancer patients, both curative and palliative. From April 2012, the audit has been extended to include patients with Oesophageal High-Grade Dysplasia (HGD).

The National Oesophago-gastric Cancer Audit is a high profile, collaborative, national clinical audit for oesophago-gastric cancer run jointly by The Health and Social Care Information Centre, The Association of Upper Gastrointestinal Surgeons of Great Britain & Ireland (AUGIS), British Society of Gastroenterologists (BSG) and The Clinical Effectiveness Unit at the Royal College of Surgeons of England.

The audit aims to improve the quality of care and survival of patients with Oesophago-gastric cancer. It meets the requirements as set out in the NHS Cancer Plan and NICE guidelines.

Accessing the data

The data are being made available on the data.gov website. Each year files of data from the National Oesophago-Gastric Cancer Audit will be made available in CSV format. Trusts and Networks are identified by name and organisation code.

What does the data cover?

The data measures levels of completeness for data submitted to the National Oesophago-Gastric Cancer Audit and measures of performance and participation in the audit at trust level for key performance measures. Further details of these can be found in the annexes of the National Oesophago-Gastric Cancer Audit Report 2014.

- Audit participation by NHS Trust and data completeness for the key fields.

- Measures about the process of care given to patients.

- Information about care outcomes and treatment.

These data do not list individual patient information, nor do they contain any patient identifiable data.

Are all Trusts included?

All Trusts in England and Wales that manage patients diagnosed with oesophago-gastric cancer are included.

What period does the data cover?

The National Oesophago-gastric Cancer Audit 2014 covers the time period from 1st April 2011 to 31st March 2013 and includes hospital sites within England and Wales.

确保临床审计数据的透明度。
在2011年7月7日致内阁部长的透明度和开放数据信函中，首相作出承诺，将国家临床审计与患者结局计划中的国家临床审计数据公开。
国家食管胃癌审计针对食管胃（OG）癌症患者的护理质量进行评估。审计不仅评估了治愈性和姑息性OG癌症患者的治疗过程和结果，而且从2012年4月起，还扩展至包括食管高级别异型增生（HGD）患者。
国家食管胃癌审计是一项高知名度、协作性的国家级临床审计，由健康与社会护理信息中心、英国及爱尔兰上消化道外科医师协会（AUGIS）、英国胃肠病学会（BSG）和英格兰皇家外科医师学院的临床有效性单位共同运营。
审计旨在提高食管胃癌患者的护理质量和生存率，符合国家癌症计划和NICE指南的规定。
数据获取
数据将在data.gov网站上提供。每年，国家食管胃癌审计的数据文件将以CSV格式提供。信托机构和组织代码以名称标识。
数据涵盖范围
这些数据衡量了提交给国家食管胃癌审计的数据的完整性水平，以及信托层面关键绩效指标的性能和参与度。更多详细信息可在《国家食管胃癌审计报告2014》的附件中找到。
- NHS信托机构的审计参与度和关键字段的完整性。
- 患者护理过程的指标。
- 关于护理结果和治疗的详细信息。
这些数据不列出任何个人患者信息，也不包含任何可识别患者身份的数据。
是否所有信托机构均包括在内？
所有管理被诊断为食管胃癌的患者的英格兰和威尔士信托机构均包括在内。
数据覆盖时间段
国家食管胃癌审计2014覆盖了从2011年4月1日至2013年3月31日的时间段，并包括英格兰和威尔士的医院站点。